Quarterly Results

JAGSONPAL PHARMACEUTICALS LTD.

NSE : JAGSNPHARMBSE : 507789ISIN CODE : INE048B01027Industry : Pharmaceuticals & DrugsHouse : Jagsonpal
BSE335.3514.35 (+4.47 %)
PREV CLOSE ( ) 321.00
OPEN PRICE ( ) 327.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4987
TODAY'S LOW / HIGH ( )322.70 336.45
52 WK LOW / HIGH ( )270.05 513.9
NSE333.3512.7 (+3.96 %)
PREV CLOSE( ) 320.65
OPEN PRICE ( ) 320.20
BID PRICE (QTY) 333.35 (47)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 38225
TODAY'S LOW / HIGH( ) 320.15 340.00
52 WK LOW / HIGH ( )273.6 514.85
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
472.34
578.29
601.53
554.51
Total Expenditure
438.38
494.64
515.16
500.14
PBIDT (Excl OI)
33.96
83.65
86.37
54.37
Other Income
25.21
22.74
19.97
25.59
Operating Profit
59.17
106.39
106.34
79.96
Interest
2.26
2.21
1.5
1.96
Exceptional Items
NA
NA
NA
NA
PBDT
56.91
104.18
104.84
78
Depreciation
4.12
4.55
3.93
4.79
Profit Before Tax
52.79
99.63
100.91
73.21
Tax
13.16
24.91
26.12
17.18
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
39.63
74.72
74.79
56.03
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
39.63
74.72
74.79
56.03
Equity Capital
131.44
130.99
130.99
130.99
Face Value (IN RS)
5
5
5
5
Reserves
Calculated EPS
1.50
2.85
2.85
2.13
Calculated EPS (Annualised)
6.03
11.40
11.41
8.55
No of Public Share Holdings
8285880
8196086
8196086
8196086
% of Public Share Holdings
31.52
31.29
31.29
31.29
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
7.18
14.46
14.35
9.80
PBIDTM%
12.52
18.39
17.67
14.41
PBDTM%
12.04
18.01
17.42
14.06
PBTM%
11.17
17.22
16.77
13.20
PATM%
8.39
12.92
12.43
10.10
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.